Drug Trial Radar · NCT00271583
Efficacy Trial of CDB 2914 for Emergency Contraception
Last checked: Nov 20, 2026Latest source record: Dec 17, 2007 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,672
Actual
Start
Sep 1999
Primary completion
Not stated
Study completion Sep 2001
Sponsor
- Lead sponsor
- University of PittsburghAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- First posted
- Jan 2, 2006
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Randomized
- Model
- Single group
- Masking
- Double
- Primary purpose
- Treatment
- Who can join
- Female only, from 18 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
Objective: To compare the efficacy, safety and tolerance of a 50 mg dose of a new antiprogestin, CDB-2914 with a 0.75 mg bid dose of levonorgestrel as emergency contraception Design: Multicenter, randomized, double blind Phase II study to compare a 50 mg dose of CDB-2914 to a 0.75 mg bid dose of levonorgestrel as emergency contraception Subjects are randomized to receive a one-time treatment with either one dose of 50 mg CDB-2914 (followed 12 hours later by a placebo) or 2 doses of 0.75 mg of levonorgestrel with follow-up visits at 5-7 days after expected onset of menses and another visit at 12-14 days after expected onset of menses (if needed) The primary aim is to evaluate the efficacy of CDB-2914 used by subjects as an emergency postcoital contraceptive in comparison to a group of subjects receiving levonorgestrel.
Conditions
- Emergency Contraception
Interventions
CDB-2914Drug
levonorgestrelDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pregnancy (efficacy)Time frame: until follow-up about one week after next menses
Locations
6 sites in 1 country. Site status is shown where the registry gives one.
California Family Health Council
Los Angeles, California
University of Colorado
Denver, Colorado
New York University
New York, New York
University of Cincinnati
Cincinnati, Ohio
University of Pittsburgh
Pittsburgh, Pennsylvania
Eastern Virginia Medical School
Norfolk, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.